Inhaled corticosteroid (ICS) for persistent asthma. The most studied ICS in pregnancy; large registry data (>2,500 exposures) confirm no increase in congenital malformations. Preferred ICS to initiate in pregnancy due to available safety data, though other ICS are considered acceptable. Systemic absorption from inhaled use is minimal. Uncontrolled asthma poses greater risk than ICS treatment.
How it works
Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.
Dosing & administration
Dosing varies by indication and patient profile. Always follow your institution's current prescribing guidelines.
Renal impairment
Consult protocols for adjustment.
Liver impairment
Consult protocols for adjustment.
Use during pregnancy
1st trimester
Safe. Preferred ICS to initiate in pregnancy if ICS therapy is indicated.
2nd trimester
Safe. Continue for asthma control.
3rd trimester
Safe.
Clinical note
Inhaled corticosteroid (ICS) for persistent asthma. The most studied ICS in pregnancy; large registry data (>2,500 exposures) confirm no increase in congenital malformations. Preferred ICS to initiate in pregnancy due to available safety data, though other ICS are considered acceptable. Systemic absorption from inhaled use is minimal. Uncontrolled asthma poses greater risk than ICS treatment.
Breastfeeding
Safe. Minimal systemic absorption; negligible breast milk transfer. Compatible with breastfeeding.
Warnings & precautions
When not to use it
Avoid in patients with known hypersensitivity to this drug or any of its components.
Drug interactions
Loading safety data…
Budesonide (Inhaled) | Drug Overview & Clinical Reference
